obesity-995x60.png
FEATURED ARTICLES
'ONE In A MILLION' Aims To Bridge The Equity Gap In Clinical Trials
Tigerlily Foundation is launching its "ONE in a MILLION" national public-private partnership to engage one million people in high-risk communities with clinical research.
-
![asian doctor with elder patients, care, trust, teamwork-GettyImages-2240196754]( "This Real-World Example Illustrates The Power Of Patient Centricity In Clinical Trials")
This Real-World Example Illustrates The Power Of Patient Centricity In Clinical TrialsArdelyx Chief Patient Officer Laura Williams, MD, MPH, reflects on how patients with chronic kidney disease (CKD) successfully guided Ardelyx’s clinical trial program.
-
![Heidi Barham]( "Site Payments Are Still a Mess, But Takeda Is Trying To Help")
Site Payments Are Still a Mess, But Takeda Is Trying To HelpIn this article, Heidi Barham, Takeda’s associate director of clinical study site payments, explains how the company is replacing opaque CRO-driven processes with real-time transparency, streamlined startup payments, and a dedicated sponsor-side team that sites can actually reach.
-
![Problems and solutions digital concept-GettyImages-1301983567]( "Begin Your AI-Led Digital Clinical Transformation With A Phased Approach")
Begin Your AI-Led Digital Clinical Transformation With A Phased ApproachDiscover how to establish a holistic AI-led digital strategy, starting with a top-down, phased approach.
SERVICES AND PRODUCTS
With an in-house donor center and database of donors, along with an established network of hospitals and care centers, Precision can source virtually any disease type or sample type biospecimens needed for your project.
As a full-service contract research organization, Southern Star Research has the knowledge, industry relationships and technical expertise to get your early-phase clinical trial up and running safely and efficiently.
Expert ophthalmic teams rescue clinical trials with stabilized studies, nationwide coverage, and eye assessments, helping protect endpoints and regain timeline control quickly.
Antibody-drug conjugates (ADCs) are transforming cancer care by combining precision antibody targeting with potent payloads to improve patient outcomes.
Inflammation is a primary pathogenic process in a wide range of diseases, including rheumatoid arthritis, cardiovascular disease, oncology and neuropsychiatric disorders.
Altasciences’ experienced team specializes in early-phase renal and hepatic impairment studies, delivering tailored clinical pharmacology trials that support your regulatory submissions.